Darlene P. Horton, Md

Darlene P. Horton, Md Email and Phone Number

Chief Medical Officer at Jaguar Health, Inc./Napo Pharmaceuticals, Inc. (wholly owned by Jaguar) @
Darlene P. Horton, Md's Location
San Francisco, California, United States, United States
Darlene P. Horton, Md's Contact Details

Darlene P. Horton, Md personal email

Darlene P. Horton, Md phone numbers

About Darlene P. Horton, Md

I am a positive-minded, energetic and accomplished biopharmaceutical clinical development expert with strong leadership, team building, development operations, and communication skills. I enjoy developing strategy as well as mastering the details. I have led full Development teams from product development to preclinical, IND, and NDA/BLA. I've also led Clinical, Regulatory Affairs, and Medical Affairs teams. My sweet spot: clinical trial design, regulatory strategy, and execution that creates approvable submissions and commercial differentiation. Therapeutic area experience includes Cardiology, Immunology, Oncology, Rheumatology, Dermatology, Gastrointestinal, Rare Diseases, Orthopedics, Endocrinology, Nephrology, Hepatology, and Neurology. I enjoy helping to drive company success with smart, well functioning project and senior management teams. BS with Honors (microbiology) and MD from Univ of Florida. Residency and Chief Residency in Pediatrics at UCSF and San Francisco General Hospital (SFGH). Pediatric Cardiology fellowship at UCSF.

Darlene P. Horton, Md's Current Company Details
Jaguar Health/Napo Pharmaceuticals, Inc. (wholly owned by Jaguar)

Jaguar Health/Napo Pharmaceuticals, Inc. (Wholly Owned By Jaguar)

Chief Medical Officer at Jaguar Health, Inc./Napo Pharmaceuticals, Inc. (wholly owned by Jaguar)
Darlene P. Horton, Md Work Experience Details
  • Jaguar Health/Napo Pharmaceuticals, Inc. (Wholly Owned By Jaguar)
    Chief Medical Officer
    Jaguar Health/Napo Pharmaceuticals, Inc. (Wholly Owned By Jaguar) May 2021 - Present
  • Horton Consulting
    Life Sciences Development And Strategy Consultant
    Horton Consulting Aug 2007 - Present
    I bring my passion and energy for patient-driven development and swift execution to projects. Senior experience and successes in both startup and large biopharmaceutical environments in multiple therapeutic areas leads to customized and focused development and strategic support for clients. Examples of specific expertise include:- clinical trial design and execution and regulatory strategy- developing strategies to maximize product value- data safety monitoring- preclinical and clinical operations- evaluation of business development opportunities and portfolio planning- business plan optimization for raising capital
  • Coherus Biosciences, Inc.
    Chief Medical & Regulatory Officer
    Coherus Biosciences, Inc. Jan 2019 - Aug 2019
    As CMO and Chief Regulatory Officer, I managed rapidly growing Clinical Research, Clinical Operations, Drug Safety/Pharmacovigilance, Medical Affairs, and Regulatory teams focused on supporting the company's first commercial product, Udenyca (pegfilgrastim-cbqv), an oncology product, and 3 additional biosimilars programs in Immunology/Rheumatology/Dermatology/GI and Ophthalmology under various phases of development.
  • Tulangco Inc.
    Co-Founder & Chief Executive Officer
    Tulangco Inc. Jun 2017 - Dec 2018
    Tulang means "bone" in the Malay language. TulangCo developed transformational bone-regenerative technology that harnesses the natural healing of the bone extracellular matrix. TulangCo believes that the orthopedic bone graft substitute market has been ripe for disruption for many years. Surgeons have been searching for an orthobiologic that really works so that growth factors or cells do not need to be added to achieve the desired bone repair or regeneration. They seek an orthobiologic that improves the clinical outcomes of their procedures with no new safety concerns.
  • Smc Biotechnology, Inc.
    Chief Medical Officer
    Smc Biotechnology, Inc. Jan 2014 - Jun 2017
    A unique regenerative medicine company that developed a large pipeline of glycotherapeutic products to enhance the body's own pro-healing growth factors and to recruit the body's own stem cells to the site of healing. One product was specifically designed to help optimize stem cell manufacturing. Glycotherapeutics are specific extracellular matrix sugars that stabilize protein-receptor interactions, facilitating their downstream biology.
  • Ucsf Pediatric Cardiology
    Clinical Faculty
    Ucsf Pediatric Cardiology Jul 1996 - Jul 2016
    Attending, Pediatric Cardiology Clinic, San Francisco General Hospital
  • Nile Therapeutics, Inc.
    President And Ceo
    Nile Therapeutics, Inc. Aug 2012 - Nov 2013
    After 1 year as CEO, the company successfully completed a reverse merger with a privately held stem cell company, creating a publicly traded company with multiple products for the prevention and treatment of heart failure.
  • Itero Biopharmaceuticals, Inc
    Co-Founder, Chief Medical Officer, Head Of Development
    Itero Biopharmaceuticals, Inc Nov 2007 - Aug 2013
    I served as CMO for this biotechnology startup focused on cost-effective development and commercially and clinically differentiated biosimilar protein therapeutics. Lead product was licensed to Watson Pharmaceuticals (now AbbVie in 2020 after multiple acquisitions). After the transactions was completed, I co-chaired the Joint Development and Joint Steering Committee between the two companies.
  • Scios Inc.
    Svp Clinical Research And Medical Affairs
    Scios Inc. 1996 - 2007
    Us
    Senior Executive, Head of Clinical Research and Medical Affairs
    View
  • Scios Inc / Johnson & Johnson Co.
    Svp Clinical Research, Head Of Tace, Cardiovascular Clinical Development
    Scios Inc / Johnson & Johnson Co. 2004 - 2006
    Provided oversight of Cardiovascular Clinical Development across JNJ companies and oversight of clinical due diligence of product candidates for in-licensing.
  • Johnson And Johnson
    Svp Clinical Research And Medical Affairs
    Johnson And Johnson 2003 - 2006
    New Brunswick, Nj, Us
    View
  • Scios (A Jnj Company)
    Svp Clinical Research And Medical Affairs, Cmo
    Scios (A Jnj Company) 1996 - 2006
  • Ucsf Intensive Care Nursery (Icn), Kaiser Hospital Icn, Sfgh, And St. Luke'S Hospital
    Staff Pediatrician And Neonatal Hospitalist
    Ucsf Intensive Care Nursery (Icn), Kaiser Hospital Icn, Sfgh, And St. Luke'S Hospital Jul 1990 - Jun 1996

Darlene P. Horton, Md Skills

Biotechnology Clinical Development Clinical Research Cardiology Biopharmaceuticals Clinical Trials Medical Affairs Drug Development Leadership Fda Private Investment Loans Cro Start Ups Life Sciences Gcp Pharmaceutical Industry Pediatric Cardiology Business Leadership Private Lending Clinical Operations Infectious Diseases Biopharmaceutical Development Clinical And Regulatory Strategy Medical Writing Protein Chemistry Oncology U.s. Food And Drug Administration

Darlene P. Horton, Md Education Details

  • University Of California, San Francisco
    University Of California, San Francisco
    Pediatric Residency And Pediatric Cardiology Fellowship
  • University Of Florida College Of Medicine
    University Of Florida College Of Medicine
    Doctor Of Medicine (M.D.)
  • University Of Florida
    University Of Florida
    General
  • University Of Florida College Of Medicine
    University Of Florida College Of Medicine
    Doctor Of Medicine - Md
  • University Of Florida College Of Medicine
    University Of Florida College Of Medicine
    Medicine
  • University Of Florida College Of Medicine
    University Of Florida College Of Medicine
    Doctor Of Medicine - Md

Frequently Asked Questions about Darlene P. Horton, Md

What company does Darlene P. Horton, Md work for?

Darlene P. Horton, Md works for Jaguar Health/napo Pharmaceuticals, Inc. (Wholly Owned By Jaguar)

What is Darlene P. Horton, Md's role at the current company?

Darlene P. Horton, Md's current role is Chief Medical Officer at Jaguar Health, Inc./Napo Pharmaceuticals, Inc. (wholly owned by Jaguar).

What is Darlene P. Horton, Md's email address?

Darlene P. Horton, Md's email address is dh****@****rus.com

What is Darlene P. Horton, Md's direct phone number?

Darlene P. Horton, Md's direct phone number is +165058*****

What schools did Darlene P. Horton, Md attend?

Darlene P. Horton, Md attended University Of California, San Francisco, University Of Florida College Of Medicine, University Of Florida, University Of Florida College Of Medicine, University Of Florida College Of Medicine, University Of Florida College Of Medicine.

What are some of Darlene P. Horton, Md's interests?

Darlene P. Horton, Md has interest in Health.

What skills is Darlene P. Horton, Md known for?

Darlene P. Horton, Md has skills like Biotechnology, Clinical Development, Clinical Research, Cardiology, Biopharmaceuticals, Clinical Trials, Medical Affairs, Drug Development, Leadership, Fda, Private Investment, Loans.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.